HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

Market Cap	210.07B
Revenue (ttm)	36.10B
Net Income (ttm)	472.66M
Shares Out	14.04M
EPS (ttm)	34.13
PE Ratio	444.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,656
Average Volume	111,873
Open	15,250
Previous Close	14,960
Day's Range	14,900 - 15,450
52-Week Range	14,230 - 33,250
Beta	0.31
RSI	30.59
Earnings Date	n/a

About HLB Pharmaceutical

HLB Pharmaceutical Co., Ltd., a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dent...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 047920